Shanghai Junshi Biosciences Co., Ltd. (OTCMKTS:SHJBF) Stock Short Interest Report for October

Shanghai Junshi Biosciences Co., Ltd. (OTCMKTS:SHJBF) saw a significant growth in short interest during the month of October. As of October 30th, there was short interest totaling 82,400 shares, a growth of 41,100.0% from the October 15th total of 200 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Shanghai Junshi Biosciences Stock Performance

Shares of OTCMKTS:SHJBF opened at C$3.35 on Wednesday. The stock’s 50-day moving average is C$3.35 and its 200 day moving average is C$3.22. Shanghai Junshi Biosciences has a 1 year low of C$2.99 and a 1 year high of C$4.23.

About Shanghai Junshi Biosciences

Shanghai Junshi Biosciences is a biopharmaceutical company founded in 2012 and headquartered in Shanghai, China. It develops innovative medicines, with research programs spanning oncology, autoimmune and metabolic diseases, and infectious diseases. The company’s best-known product is toripalimab, an anti-PD-1 antibody marketed in China as Tuoyi and in the United States as Loqtorzi. It is used for certain cancers, including nasopharyngeal carcinoma. Junshi also develops a pipeline of antibody-based and other therapies at different stages of research and clinical development.